✦ LIBER ✦

P-224 XPD polymorphisms in cisplatin (cis)/vinorelbine (vrb)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p): genetic analysis of a Spanish Lung Cancer Group phase II trial

✍ Scribed by Vin˜olas, Nuria; Roig, Barbara; Reguart, Noemi; Provencio, Mariano; Cardenal, Felipe; Margeli, Mireja; Baron-Duarte, Francisco Javier; Alberola, Vicente; Cobo, Manuel; Rosell, Rafael

Book ID: 118571925
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 178 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92193-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-220 Polymorphisms in DNA repair genes

P-220 Polymorphisms in DNA repair genes and survival in cisplatin (cis)/docetaxel (doc)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p): a Spanish Lung Cancer Group phase II trial

✍ Isla, Dolores; Queralt, Cristina; Alonso, Guillermo; Domine, Manuel; Barcelo, Ra 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

P-225 XPD and RRM1 gene polymorphisms pr

P-225 XPD and RRM1 gene polymorphisms predict gemcitabine (gem)/cisplatin (cis)/docetaxel (doc) outcome in stage III non-small-cell lung cancer (NSCLC): a genetic analysis of the Spanish Lung Cancer Group phase II trial 9901

✍ Sarries, Carme; Garrido, Pilar; Nun˜ez, Laura; Roig, Barbara; Ramirez, Jose Luis 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

P-439 Chemotherapy-radiotherapy multimod

P-439 Chemotherapy-radiotherapy multimodalities with vinorelbine-cisplatin for stage IIIB non small cell lung cancer patients (NSCLC pts): Results from a Morrocan Phase II trial

✍ Acharki, A.; Jouhadi, H.; Benchakroun, N.; Sahraoui, S.; Tawfiq, N.; Boulder, A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

A phase II study with vinorelbine, gemci

A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb–IV non-small cell lung cancer (NSCLC)

✍ Ginopoulos, P.; Mastronikolis, N.S.; Giannios, J.; Karana, A.; Siabi, V.; Karvel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Multicenter randomized phase II trial as

Multicenter randomized phase II trial assessing docetaxel (D) alternating with cisplatin (C) and vinorelbine (V) versus cisplatin (C) - vinorelbine (V) in stage IV non-small-cell lung cancer (NSCLC)

✍ Pérol, M; Lena, H; Thomas, P; Robinet, G; Fournel, P; Coste, E; Belleguic, C; Le 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

P-588 Biweekly docetaxel and vinorelbine

P-588 Biweekly docetaxel and vinorelbine as second-line treatment in advanced (stage IIIB+ IV) non-small-cell lung cancer (NSCLC). A phase II study of the Galician Lung Cancer Group

✍ Vázquez, S.; Villanueva, M.; Amenedo, M.; Firvida, J.; Lázaro, M.; Del Río, L.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB